Palantir (NASDAQ: PLTR) has been one of the stock market's biggest success stories over the last two years. Shares of the AI software company, which is best known for its work with government defense ...

Palantir Technologies Inc.'s 30% dip signals a buying opportunity amid growth in AI investments and defense spending. Click ...

NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framework, reigniting debate ...

The data analysis and surveillance company is the darling of Wall Street for its use of artificial intelligence in defense ...

We are featuring all the reaction to the news of NHS England being scrapped and merged into the Department of Health and ...

NHS England – will be abolished in a bid to cut red tape and “free up” cash for front line services, Sir Keir Starmer has ...

Palantir stock has pulled back sharply in the past few weeks. The AI stock still trades at a sky-high valuation. Tariffs and other macro headwinds could put pressure on the stock. Along the way ...

Palantir shares tumbled Monday, extending losses over the past month. The artificial intelligence analytics company's stock has lost almost 40% of its value since closing at a record high on Feb ...

In healthcare we trust—or do we? A breakdown in trust, like the schism in the transatlantic alliance, should make us think again about whether the current model requires reinvention. An anonymous ...

NHS chief data and analytics officers are worried about the way NHS England is running its Federated Data Platform programme.

Palantir does have a number of major clients in Europe, including the U.K.'s National Health Service (NHS), but the company's sluggish performance in Europe may reflect the reputational risk of ...

Palantir (NASDAQ: PLTR) was one of the biggest winners of 2024 on the stock market, delivering a monster gain of 341%. Along the way, it reported accelerating revenue growth and improving ...